The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Liver Diseases

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Liver Diseases


Psychiatry related information on Liver Diseases


High impact information on Liver Diseases


Chemical compound and disease context of Liver Diseases


Biological context of Liver Diseases


Anatomical context of Liver Diseases


Gene context of Liver Diseases


Analytical, diagnostic and therapeutic context of Liver Diseases


  1. Hepatitis B virus immunopathogenesis. Chisari, F.V., Ferrari, C. Annu. Rev. Immunol. (1995) [Pubmed]
  2. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M.E., Raimondo, G. N. Engl. J. Med. (1999) [Pubmed]
  3. Magnetic-susceptibility measurement of human iron stores. Brittenham, G.M., Farrell, D.E., Harris, J.W., Feldman, E.S., Danish, E.H., Muir, W.A., Tripp, J.H., Bellon, E.M. N. Engl. J. Med. (1982) [Pubmed]
  4. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. Moore, K., Wendon, J., Frazer, M., Karani, J., Williams, R., Badr, K. N. Engl. J. Med. (1992) [Pubmed]
  5. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Strautnieks, S.S., Bull, L.N., Knisely, A.S., Kocoshis, S.A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., Tanner, M.S., Kagalwalla, A.F., Németh, A., Pawlowska, J., Baker, A., Mieli-Vergani, G., Freimer, N.B., Gardiner, R.M., Thompson, R.J. Nat. Genet. (1998) [Pubmed]
  6. Visual event-related P300 potentials in early portosystemic encephalopathy. Kügler, C.F., Lotterer, E., Petter, J., Wensing, G., Taghavy, A., Hahn, E.G., Fleig, W.E. Gastroenterology (1992) [Pubmed]
  7. Gamma-glutamyltransferase and diabetes--a 4 year follow-up study. Lee, D.H., Ha, M.H., Kim, J.H., Christiani, D.C., Gross, M.D., Steffes, M., Blomhoff, R., Jacobs, D.R. Diabetologia (2003) [Pubmed]
  8. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Hickman, I.J., Jonsson, J.R., Prins, J.B., Ash, S., Purdie, D.M., Clouston, A.D., Powell, E.E. Gut (2004) [Pubmed]
  9. Z score prediction model for assessment of bone mineral content in pediatric diseases. Ellis, K.J., Shypailo, R.J., Hardin, D.S., Perez, M.D., Motil, K.J., Wong, W.W., Abrams, S.A. J. Bone Miner. Res. (2001) [Pubmed]
  10. Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Arria, A.M., Tarter, R.E., Warty, V., Van Thiel, D.H. Am. J. Clin. Nutr. (1990) [Pubmed]
  11. Keratin 8 mutations in patients with cryptogenic liver disease. Ku, N.O., Gish, R., Wright, T.L., Omary, M.B. N. Engl. J. Med. (2001) [Pubmed]
  12. Methotrexate therapy and liver disease. Dufour, J.F., Kaplan, M.M. N. Engl. J. Med. (1996) [Pubmed]
  13. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Smit, J.J., Schinkel, A.H., Oude Elferink, R.P., Groen, A.K., Wagenaar, E., van Deemter, L., Mol, C.A., Ottenhoff, R., van der Lugt, N.M., van Roon, M.A. Cell (1993) [Pubmed]
  14. Conjugated estrogen for platelet dysfunction associated with liver disease. Perez, E.A., Tanaka, M., Gandara, D.R. N. Engl. J. Med. (1988) [Pubmed]
  15. Acute rhabdomyolysis associated with cocaine intoxication. Roth, D., Alarcón, F.J., Fernandez, J.A., Preston, R.A., Bourgoignie, J.J. N. Engl. J. Med. (1988) [Pubmed]
  16. Peptic ulcer, prednisone and serum gastrin in chronic active liver disease. Uribe, M., Go, V.L., Summerskill, W.H. N. Engl. J. Med. (1977) [Pubmed]
  17. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. Pascal, J.P., Cales, P. N. Engl. J. Med. (1987) [Pubmed]
  18. Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease. LaRusso, N.F., Hoffman, N.E., Hofmann, A.F., Korman, M.G. N. Engl. J. Med. (1975) [Pubmed]
  19. Halothane hepatitis. Detection of a constitutional susceptibility factor. Farrell, G., Prendergast, D., Murray, M. N. Engl. J. Med. (1985) [Pubmed]
  20. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. Hostetter, M.K., Levy, H.L., Winter, H.S., Knight, G.J., Haddow, J.E. N. Engl. J. Med. (1983) [Pubmed]
  21. On the TRAIL to therapeutic intervention in liver disease. Herr, I., Schemmer, P., Büchler, M.W. Hepatology (2007) [Pubmed]
  22. Liver disease in adult patients with cystic fibrosis: A frequent and independent prognostic factor associated with death or lung transplantation. Chryssostalis, A., Hubert, D., Coste, J., Kanaan, R., Burgel, P.R., Desmazes-Dufeu, N., Soubrane, O., Dusser, D., Sogni, P. J. Hepatol. (2011) [Pubmed]
  23. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Strand, S., Hofmann, W.J., Grambihler, A., Hug, H., Volkmann, M., Otto, G., Wesch, H., Mariani, S.M., Hack, V., Stremmel, W., Krammer, P.H., Galle, P.R. Nat. Med. (1998) [Pubmed]
  24. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Lavon, I., Goldberg, I., Amit, S., Landsman, L., Jung, S., Tsuberi, B.Z., Barshack, I., Kopolovic, J., Galun, E., Bujard, H., Ben-Neriah, Y. Nat. Med. (2000) [Pubmed]
  25. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Grompe, M., al-Dhalimy, M., Finegold, M., Ou, C.N., Burlingame, T., Kennaway, N.G., Soriano, P. Genes Dev. (1993) [Pubmed]
  26. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis. Yoshida, T., Ogata, H., Kamio, M., Joo, A., Shiraishi, H., Tokunaga, Y., Sata, M., Nagai, H., Yoshimura, A. J. Exp. Med. (2004) [Pubmed]
  27. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. Rifai, A., Fadden, K., Morrison, S.L., Chintalacharuvu, K.R. J. Exp. Med. (2000) [Pubmed]
  28. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Willenbring, H., Bailey, A.S., Foster, M., Akkari, Y., Dorrell, C., Olson, S., Finegold, M., Fleming, W.H., Grompe, M. Nat. Med. (2004) [Pubmed]
  29. Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease. Husby, G., Strickland, R.G., Caldwell, J.L., Williams, R.C. J. Clin. Invest. (1975) [Pubmed]
  30. Erythrocyte porphobilinogen deaminase activity in liver disease. Ostrowski, J. Gastroenterology (1987) [Pubmed]
  31. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Rose, C., Butterworth, R.F., Zayed, J., Normandin, L., Todd, K., Michalak, A., Spahr, L., Huet, P.M., Pomier-Layrargues, G. Gastroenterology (1999) [Pubmed]
  32. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Crawford, D.H., Shepherd, R.W., Halliday, J.W., Cooksley, G.W., Golding, S.D., Cheng, W.S., Powell, L.W. Gastroenterology (1994) [Pubmed]
  33. Regulation of cyp3a gene transcription by the pregnane x receptor. Goodwin, B., Redinbo, M.R., Kliewer, S.A. Annu. Rev. Pharmacol. Toxicol. (2002) [Pubmed]
  34. Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice. Ruppert, S., Kelsey, G., Schedl, A., Schmid, E., Thies, E., Schütz, G. Genes Dev. (1992) [Pubmed]
  35. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. Marra, F., Valente, A.J., Pinzani, M., Abboud, H.E. J. Clin. Invest. (1993) [Pubmed]
  36. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. Canbay, A., Guicciardi, M.E., Higuchi, H., Feldstein, A., Bronk, S.F., Rydzewski, R., Taniai, M., Gores, G.J. J. Clin. Invest. (2003) [Pubmed]
  37. Liver transplantation for advanced liver disease with alpha-1-antitrypsin deficiency. Hood, J.M., Koep, L.J., Peters, R.L., Schröter, G.P., Weil, R., Redeker, A.G., Starzl, T.E. N. Engl. J. Med. (1980) [Pubmed]
  38. Splanchnic transplantation. An approach to the infant dependent on parenteral nutrition who develops irreversible liver disease. Williams, J.W., Sankary, H.N., Foster, P.F., Loew, J.M., Goldman, G.M., Lowe, J. JAMA (1989) [Pubmed]
  39. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. Liu, Y., Binz, J., Numerick, M.J., Dennis, S., Luo, G., Desai, B., MacKenzie, K.I., Mansfield, T.A., Kliewer, S.A., Goodwin, B., Jones, S.A. J. Clin. Invest. (2003) [Pubmed]
  40. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. Bradbear, R.A., Bain, C., Siskind, V., Schofield, F.D., Webb, S., Axelsen, E.M., Halliday, J.W., Bassett, M.L., Powell, L.W. J. Natl. Cancer Inst. (1985) [Pubmed]
WikiGenes - Universities